YAP and TAZ are transcriptional co-activators of AP-1 proteins and STAT3 during breast cellular transformation.


Journal

eLife
ISSN: 2050-084X
Titre abrégé: Elife
Pays: England
ID NLM: 101579614

Informations de publication

Date de publication:
31 08 2021
Historique:
received: 07 02 2021
accepted: 26 08 2021
pubmed: 1 9 2021
medline: 21 10 2021
entrez: 31 8 2021
Statut: epublish

Résumé

The YAP and TAZ paralogs are transcriptional co-activators recruited to target sites by TEAD proteins. Here, we show that YAP and TAZ are also recruited by JUNB (a member of the AP-1 family) and STAT3, key transcription factors that mediate an epigenetic switch linking inflammation to cellular transformation. YAP and TAZ directly interact with JUNB and STAT3 via a WW domain important for transformation, and they stimulate transcriptional activation by AP-1 proteins. JUNB, STAT3, and TEAD co-localize at virtually all YAP/TAZ target sites, yet many target sites only contain individual AP-1, TEAD, or STAT3 motifs. This observation and differences in relative crosslinking efficiencies of JUNB, TEAD, and STAT3 at YAP/TAZ target sites suggest that YAP/TAZ is recruited by different forms of an AP-1/STAT3/TEAD complex depending on the recruiting motif. The different classes of YAP/TAZ target sites are associated with largely non-overlapping genes with distinct functions. A small minority of target sites are YAP- or TAZ-specific, and they are associated with different sequence motifs and gene classes from shared YAP/TAZ target sites. Genes containing either the AP-1 or TEAD class of YAP/TAZ sites are associated with poor survival of breast cancer patients with the triple-negative form of the disease.

Identifiants

pubmed: 34463254
doi: 10.7554/eLife.67312
pii: 67312
pmc: PMC8463077
doi:
pii:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Intracellular Signaling Peptides and Proteins 0
JunB protein, human 0
STAT3 Transcription Factor 0
STAT3 protein, human 0
Transcription Factor AP-1 0
Transcription Factors 0
Transcriptional Coactivator with PDZ-Binding Motif Proteins 0
WWTR1 protein, human 0
YAP-Signaling Proteins 0
YAP1 protein, human 0

Banques de données

GEO
['GSE166943', 'GSE115597', 'GSE115598', 'GSE100259']

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NCI NIH HHS
ID : R01 CA107486
Pays : United States
Organisme : NHGRI NIH HHS
ID : U24 HG009446
Pays : United States

Informations de copyright

© 2021, He et al.

Déclaration de conflit d'intérêts

LH, MG, FW, ZW None, HP none, KS Senior editor, eLife

Références

Bioinformatics. 2011 Jun 15;27(12):1696-7
pubmed: 21486936
Cell Rep. 2016 Feb 9;14(5):1169-1180
pubmed: 26832411
Genome Res. 2012 Sep;22(9):1813-31
pubmed: 22955991
J Biol Chem. 2018 Jul 13;293(28):11230-11240
pubmed: 29802201
EMBO J. 2018 Sep 3;37(17):
pubmed: 30037824
Genes Dev. 2020 Jan 1;34(1-2):72-86
pubmed: 31831627
Mol Cell. 2010 Aug 27;39(4):493-506
pubmed: 20797623
Epigenetics Chromatin. 2015 Feb 14;8:7
pubmed: 25784959
Nucleic Acids Res. 2019 Jan 8;47(D1):D419-D426
pubmed: 30407594
Development. 2014 Apr;141(8):1614-26
pubmed: 24715453
Cancer Res. 2020 Oct 1;80(19):4145-4157
pubmed: 32816858
Genes Dev. 2011 Dec 1;25(23):2525-39
pubmed: 22156212
Genome Res. 2012 Sep;22(9):1798-812
pubmed: 22955990
Nat Cell Biol. 2015 Sep;17(9):1218-27
pubmed: 26258633
Mol Cell. 2002 Apr;9(4):799-809
pubmed: 11983171
Nat Med. 2018 Oct;24(10):1599-1610
pubmed: 30224758
BMC Bioinformatics. 2009 Feb 03;10:48
pubmed: 19192299
Nature. 2020 Aug;584(7820):244-251
pubmed: 32728217
Cell. 2009 Nov 13;139(4):693-706
pubmed: 19878981
Genome Biol. 2014;15(12):550
pubmed: 25516281
Nat Rev Drug Discov. 2014 Jan;13(1):63-79
pubmed: 24336504
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9453-9462
pubmed: 30910960
Nucleic Acids Res. 2020 Jan 8;48(D1):D87-D92
pubmed: 31701148
Nat Biotechnol. 2013 Sep;31(9):827-32
pubmed: 23873081
Mol Cell. 2006 Nov 17;24(4):593-602
pubmed: 17188034
Nucleic Acids Res. 2015 Jul 1;43(W1):W39-49
pubmed: 25953851
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5708-13
pubmed: 25902495
Nature. 2020 Jul;583(7818):699-710
pubmed: 32728249
Nucleic Acids Res. 2004 Nov 01;32(19):e151
pubmed: 15520460
Cell. 2012 Dec 21;151(7):1457-73
pubmed: 23245941
Cell Rep. 2013 Dec 26;5(6):1611-24
pubmed: 24332857
Genome Res. 2013 Aug;23(8):1195-209
pubmed: 23595228
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Blood Cancer J. 2019 Jan 3;9(1):2
pubmed: 30607001
Mol Cell. 2011 Oct 7;44(1):62-71
pubmed: 21856198
Nucleic Acids Res. 2018 Jan 4;46(D1):D252-D259
pubmed: 29140464
BMC Med Genomics. 2015 Aug 22;8:54
pubmed: 26297356
Nature. 2018 Nov;563(7730):265-269
pubmed: 30401838
Physiol Rev. 2014 Oct;94(4):1287-312
pubmed: 25287865
Cancer Res. 2020 Nov 1;80(21):4768-4779
pubmed: 32900774
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Cell. 2015 Nov 5;163(4):811-28
pubmed: 26544935
Elife. 2019 Jan 25;8:
pubmed: 30681409
Genome Res. 2012 Sep;22(9):1760-74
pubmed: 22955987
Cancer Cell. 2016 Jun 13;29(6):783-803
pubmed: 27300434
J Biol Chem. 2002 Apr 5;277(14):12001-8
pubmed: 11812781
PLoS Genet. 2011 Aug;7(8):e1002207
pubmed: 21852951
Nat Commun. 2018 May 25;9(1):2068
pubmed: 29802342
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Elife. 2021 Aug 31;10:
pubmed: 34463254
Mol Cell. 2016 Nov 3;64(3):443-454
pubmed: 27773675
Nature. 2012 Jan 18;483(7389):295-301
pubmed: 22258509
Nat Rev Mol Cell Biol. 2019 Apr;20(4):211-226
pubmed: 30546055
Science. 2000 May 19;288(5469):1244-8
pubmed: 10818000
Nat Cell Biol. 2018 Aug;20(8):888-899
pubmed: 30050119
Cell. 2009 Apr 3;137(1):87-98
pubmed: 19345189
Annu Rev Biochem. 2019 Jun 20;88:577-604
pubmed: 30566373

Auteurs

Lizhi He (L)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.

Henry Pratt (H)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States.

Mingshi Gao (M)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States.

Fengxiang Wei (F)

Genetics Laboratory, Shenzhen Longgang District Maternity and Child Healthcare Hospital, Shenzhen, China.

Zhiping Weng (Z)

Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, United States.

Kevin Struhl (K)

Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH